Isolating Circulating Cancer Stem Cells (CCSCs) from Human Whole Blood
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature..
Measuring circulating tumor cells (CTCs) or circulating cancer stem cells (CCSCs) in blood, which shed from primary tumors, is a noninvasive method to screen and/or diagnose patients with a high risk of developing metastatic cancers or relapse. Here, we describe an optimized and standardized laboratory method for isolating CCSCs from human blood samples, using cancer-specific stem cell biomarkers (Kantara et al., Lab Invest 95:100-112, 2015). When performing this technique, 0-1 circulating epithelial tumor cells/mL blood should be expected in patients free of malignant adenocarcinomas compared to over 3 circulating cancer stem cells/mL blood in patients positive for malignant adenocarcinomas (Kantara et al., Lab Invest 95:100-112, 2015).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2777 |
---|---|
Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 2777(2024) vom: 13., Seite 205-218 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kantara, Carla [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 15.03.2024 Date Revised 15.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/978-1-0716-3730-2_15 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369680588 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369680588 | ||
003 | DE-627 | ||
005 | 20240315234035.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240315s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/978-1-0716-3730-2_15 |2 doi | |
028 | 5 | 2 | |a pubmed24n1330.xml |
035 | |a (DE-627)NLM369680588 | ||
035 | |a (NLM)38478346 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kantara, Carla |e verfasserin |4 aut | |
245 | 1 | 0 | |a Isolating Circulating Cancer Stem Cells (CCSCs) from Human Whole Blood |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.03.2024 | ||
500 | |a Date Revised 15.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. | ||
520 | |a Measuring circulating tumor cells (CTCs) or circulating cancer stem cells (CCSCs) in blood, which shed from primary tumors, is a noninvasive method to screen and/or diagnose patients with a high risk of developing metastatic cancers or relapse. Here, we describe an optimized and standardized laboratory method for isolating CCSCs from human blood samples, using cancer-specific stem cell biomarkers (Kantara et al., Lab Invest 95:100-112, 2015). When performing this technique, 0-1 circulating epithelial tumor cells/mL blood should be expected in patients free of malignant adenocarcinomas compared to over 3 circulating cancer stem cells/mL blood in patients positive for malignant adenocarcinomas (Kantara et al., Lab Invest 95:100-112, 2015) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Buffy coat | |
650 | 4 | |a Cancer stem cell biomarkers | |
650 | 4 | |a Circulating cancer stem cells | |
650 | 4 | |a Depletion | |
650 | 4 | |a Human blood | |
650 | 4 | |a Immunofluorescence | |
650 | 4 | |a Red blood cells | |
650 | 4 | |a Spheroids | |
650 | 4 | |a White blood cells | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
700 | 1 | |a Singh, Pomila |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 2777(2024) vom: 13., Seite 205-218 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
773 | 1 | 8 | |g volume:2777 |g year:2024 |g day:13 |g pages:205-218 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-0716-3730-2_15 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2777 |j 2024 |b 13 |h 205-218 |